Truist Financial Has Lowered Expectations for Option Care Health (NASDAQ:OPCH) Stock Price

Option Care Health (NASDAQ:OPCH) had its target price cut by analysts at Truist Financial from $41.00 to $34.00 in a research note issued to investors on Friday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Truist Financial’s target price points to a potential upside of 47.57% from the stock’s previous close.

OPCH has been the topic of several other research reports. Jefferies Financial Group lowered shares of Option Care Health from a “buy” rating to a “hold” rating and dropped their price objective for the company from $38.00 to $26.00 in a report on Thursday. JMP Securities upped their price target on Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research note on Monday, September 30th. Bank of America cut Option Care Health from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $43.00 to $29.00 in a research note on Wednesday. Finally, Barrington Research lowered their target price on Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a research report on Thursday. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat, Option Care Health presently has a consensus rating of “Moderate Buy” and an average target price of $31.60.

Option Care Health Stock Down 2.2 %

Shares of NASDAQ:OPCH opened at $23.04 on Friday. Option Care Health has a 1 year low of $22.84 and a 1 year high of $34.63. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.36. The business’s 50-day moving average is $30.65 and its 200-day moving average is $29.97. The company has a market capitalization of $3.94 billion, a price-to-earnings ratio of 19.36, a P/E/G ratio of 1.79 and a beta of 1.29.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $0.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.31 by $0.05. The firm had revenue of $1.28 billion for the quarter, compared to analysts’ expectations of $1.22 billion. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. Equities research analysts predict that Option Care Health will post 1.22 earnings per share for the current year.

Insider Buying and Selling at Option Care Health

In other news, CFO Michael H. Shapiro sold 23,217 shares of the stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the sale, the chief financial officer now directly owns 247,317 shares of the company’s stock, valued at $7,654,461.15. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other Option Care Health news, CFO Michael H. Shapiro sold 23,217 shares of the stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the sale, the chief financial officer now owns 247,317 shares in the company, valued at approximately $7,654,461.15. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Elizabeth Quadros Betten sold 47,531 shares of the business’s stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total value of $1,477,738.79. Following the completion of the transaction, the director now owns 21,339 shares in the company, valued at $663,429.51. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.64% of the company’s stock.

Institutional Investors Weigh In On Option Care Health

A number of hedge funds have recently made changes to their positions in the business. UMB Bank n.a. increased its holdings in Option Care Health by 937.5% during the third quarter. UMB Bank n.a. now owns 830 shares of the company’s stock worth $26,000 after buying an additional 750 shares during the last quarter. GAMMA Investing LLC grew its holdings in Option Care Health by 110.6% during the third quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after purchasing an additional 471 shares during the period. Whittier Trust Co. of Nevada Inc. increased its position in Option Care Health by 3,362.8% in the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock worth $47,000 after buying an additional 1,446 shares during the last quarter. Blue Trust Inc. raised its stake in shares of Option Care Health by 14.8% in the second quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock valued at $81,000 after buying an additional 377 shares during the period. Finally, SageView Advisory Group LLC purchased a new position in shares of Option Care Health during the 1st quarter valued at $85,000. 98.05% of the stock is currently owned by institutional investors.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.